Technical Paper Overview
Laser Tweezers Raman Spectroscopy: Single-Cell Cancer Diagnostics
Microfluidic flow control, not operator skill, decides whether LTRS scales clinical.
Bulk tissue analysis averages out the very single-cell features that matter most for cancer diagnostics and drug-response studies. Raman spectroscopy is label-free and non-destructive — ideal for living cells — but Raman scattering is inefficient, signal collection takes seconds, and cells must be held perfectly still during acquisition. Traditional optical-trap-plus-Raman benches require constant operator intervention, blocking translation from research lab to clinical workflow.
This technical paper documents an automated LTRS arrangement combining a low-cost microfluidic flow chamber, a syringe pump, and dual-wavelength Novanta Laser Quantum ventus lasers — ventus 1064 (TEM00, M² 95% accuracy in 2-second acquisitions.
Key takeaways include:
- Why bulk tissue Raman misses what single-cell LTRS catches: cytochrome-c and nucleic-acid signatures that distinguish circulating tumour cells from white blood cells
- How dual-wavelength LTRS works: 1064 nm traps cells in a pico-Newton optical gradient; 532 nm excites resonant Raman bands diagnostic of disease state
- When to specify dual-wavelength over single-laser LTRS: clinical-grade discrimination, drug-cell interaction studies, late-stage prostate cancer staging
- What the ventus pair delivers: M² <1.4 trap beam, 1 cm⁻¹ Raman line width, <10 μrad/°C pointing stability across both wavelengths, RS232 + LabVIEW control
- A practical workflow: microfluidic flow chamber + syringe pump + co-aligned ventus pair → automated single-cell capture and spectrum acquisition
Download the full technical paper for the experimental LTRS optical layout, the PC-3 vs. Jurkat Raman spectra showing the cytochrome-c discrimination band, and the Linear Discriminate Analysis classification results — before specifying a single-wavelength LTRS bench that locks your team into manual cell-capture and limits acquisition speed.